ArticleTechniques in coloproctology2026
Patient reported outcome measures in intra-peritoneal adhesive disease: a scoping review.
Article in Techniques in coloproctology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntra-peritoneal adhesive disease (IPAD) can lead to debilitating symptoms including bowel obstruction, chronic abdominopelvic pain, and infertility. Standard tools to evaluate patient experiences for this disease process have not been described. This scoping review aims to (1) identify existing Patient Reported Outcome Measures (PROMs) related to IPAD and (2) evaluate the utility and quality of available IPAD-related PROMs, measured by predefined adhesive disease domains.
methodsSystematic searches were completed in PubMed using terms specific to IPAD-related symptoms and Quality of Life (QoL) domains including chronic abdominopelvic pain, bowel obstruction and function, and psychological impact on QoL. PROMs that reported exclusively on QoL were excluded. PROM development setting, psychometrics, and inclusion of adhesive disease domains were compared.
resultsOf 3290 articles originally identified, 38 articles yielded 10 PROMs related to IPAD. Patient input was considered in 80% of PROM development and 60% of field testing. Reliability testing and construct validity was performed for 70% of IPAD-related PROMs. All 10 IPAD-related PROMs assessed symptoms and QoL domains (i.e. chronic abdominopelvic pain, bowel obstruction/dysfunction, and impact on QoL). No PROM specific to IPAD was identified. The Memorial Sloan Kettering Bowel Function Instrument (MSK-BFI) included the fewest (3/10) and the Small Bowel Obstruction Questionnaire (SBO-Q) covered the most IPAD-related domains (9/10).
conclusionsThere is currently no IPAD-specific PROM, though the SBO-Q was identified as the most robust, as it addressed multiple symptom/QoL domains and underwent reliability/construct validity testing. Future directions include external validation of the SBO-Q in IPAD-relevant patient populations and further refinement of an IPAD-specific PROM with patient and expert input.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.